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ULK1Autophagy is a catabolic process involving autophagosome formation via lysosome. However, the
initiation step of autophagy is largely unknown. We found an interaction between ULK1 and
ATG9 in mammalian cells and utilized the interaction to identify novel regulators of autophagy
upstream of ULK1. We established a cell-based screening assay employing bimolecular ﬂuorescence
complementation. By performing gain-of-function screening, we identiﬁed G6PT as an autophagy
activator. G6PT enhanced the interaction between N-terminal Venus-tagged ULK1 and C-terminal
Venus-tagged ATG9, and increased autophagic ﬂux independent of its transport activity. G6PT neg-
atively regulated mTORC1 activity, demonstrating that G6PT functions upstream of mTORC1 in stim-
ulating autophagy.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Macroautophagy, autophagy hereafter, is an intracellular
degradation system and is initiated by the formation of a
double-membrane vesicle, called an autophagosome, which fuses
with lysosomes to degrade cytoplasmic components [1].
Autophagy degrades subcellular organelles such as mitochondria
and large protein aggregates [2]. Since autophagy contributes to
cell growth, adaptation, and differentiation, its malfunction is inti-
mately associated with human diseases [3–5]. Autophagy is acti-
vated under nutrient deprivation to maintain cellular metabolic
homeostasis [6]. Amino acid starvation induces autophagy byinhibiting mTORC1, which is under the modulation of Rag
GTPases [7]. On the other hand, mTORC1 inhibits autophagy by
phosphorylating ULK1 [8] and AMBRA, an E3 ligase, to ubiquitinate
ULK1 for degradation [9]. During glucose starvation, AMPK acti-
vates ULK1 and TSC2 or inhibits Raptor [10,11]. Autophagy is also
regulated by cellular stresses. ER stress affects starvation-induced
autophagy through eIF2a [12,13]. However, prolonged ER stress
impairs autophagy via IRE1 [14]. During hypoxia, HIF1a increases
BNIP3 and BNIP3L (NIX) to initiate autophagy [15], and PERK
increases LC3 and ATG5 to control autophagosome formation
[16]. In line with the identiﬁcation of new autophagy signals, elu-
cidation of signal modulators is necessary for a better understand-
ing of the autophagy mechanism.
To date, about 30 autophagy-related genes (ATGs) have been
reported to be required for autophagosome biogenesis [17].
Among them, ULK1 is required for the initiation step of autophagy.
ULK1, a serine/threonine kinase, forms complexes with FIP200,
ATG13, and ATG101 [18,19], and the complexes are mainly con-
trolled by mTORC 1 [8,19] and AMPK [11]. The kinase activity of
ULK1 is required for the recruitment of VPS34 to isolation mem-
brane [20,21]. Unlike other ATG proteins, ATG9 is a membrane pro-
tein containing six trans-membrane domains. ATG9 shuttles
H.-H. Ahn et al. / FEBS Letters 589 (2015) 2100–2109 2101between autophagosomes and the trans Golgi network during
autophagosome biogenesis to deliver membrane source to
autophagosomes [22]. The movement of ATG9 is dependent on
the activity of the ULK1 with class III PI3K complex. Moreover, like
ATG16L1, ATG9 functions to trafﬁc vesicles derived from the
plasma membrane [23]. In yeast, Atg1, an ULK1 homolog, interacts
with Atg9 through Atg17, a counterpart of FIP200, and the interac-
tion is increased by autophagy activation [24]. A recent study also
reported an interaction between Atg1 and Atg9 in Drosophila dur-
ing starvation-induced autophagy [25]. However, this interaction
has not been revealed in higher eukaryotes.
Glucose-6-phosphate transporter (G6PT) is embedded in the ER
membrane by 10 transmembrane domains [26]. It functions to
transport cytosolic glucose-6-phosphate (G6P) into the ER lumen
during gluconeogenesis or glycogenolysis by complexing with
glucose-6-phosphatase (G6Pase)-a (in the liver, kidney, and intes-
tine) or -P (in neutrophils). Accordingly, deﬁciency of G6PT/G6Pase
complex causes glycogen storage disease (GSD), leading to the
homeostatic imbalance of glucose [27]. To identify regulators of
the initiation step of autophagy, we performed cell-based func-
tional screening. We identiﬁed G6PT as an autophagy activator
and hypothesized that it regulates autophagy through mTORC1.
2. Materials and methods
2.1. DNA Constructs
ULK1, ATG9 and G6PT cDNAs were subcloned into BglII/XbaI of
pFLAG-VN173, ApnI of pHA-VC155, and HindIII site of pcDNA3-HA
(Invitrogen). Bimolecular ﬂuorescence complementation (BiFC)
assay was performed as described [28]. G6PT shRNAs were con-
structed using forward and reverse synthetic 19-base sequences
(#1, 50-1243CGA AAC ATC CGC ACC AAG A-30; #2, 50-107CAT CAT
TGG AAG AGA T-30), which were cloned into BglIUHindIII sites of
pSuper-neo (Oligoengine). The pHTTex120-GFP, which is a frag-
ment of Huntingtin (HTT) exon1 containing expanded polyglu-
tamine (n = 120) fused to GFP, was described [14].
2.2. Cell culture and DNA transfection
HEK293T and m5-7 cells were cultured in DMEM and Hep3B
cells in RPMI 1640 supplemented with 10% fetal bovine serum
(HyClone) at 37 C under an atmosphere of 5% CO2. Transfection
was carried out using Polyfect reagent (Qiagen), according to the
manufacturer’s instructions.
2.3. Site-directed mutagenesis
G6PT (R28H, G149E, A373D) mutants were generated using a
Quickchange Site-Directed Mutagenesis kit (Stratagene) and syn-
thetic oligonucleotides containing mutations in the corresponding
positions.
2.4. Generation of stable cell lines
Hep3B cells were transfected with pcDNA3-HA, pG6PT-HA, or
pG6PT shRNA for 24 h and grown in the media containing
1 mg/mL G418 sulfate (Invitrogen) for 2 weeks. Then, single clones
of stable cells were isolated using the standard selection method.
2.5. Antibodies and Western blot analysis
Cell extracts were prepared and analyzed as previously
described [14]. Immunoreactive proteins were visualized using
an enhanced chemiluminescence method. The following antibod-
ies were used for Western blot analysis: LC3, ATG5, Beclin1(Novus), ATG9A (Novus, Cell signaling), pS6K, S6K, pAMPK,
AMPK, p4E-BP1, 4E-BP1, pULK1 (Cell signaling), FLAG (Sigma),
p62 (Abnova), actin, ULK1, GFP (Santa Cruz Biotechnology), and
G6PT (Abcam).
2.6. Immunoprecipitation assay
Cells were lyzed in RIPA buffer (50 mM Tris–Cl pH 7.5, 50 mM
NaCl, 1% Triton X-100, 0.2% SDS, 1 mM EDTA, and 1 mM PMSF).
After clarifying by centrifugation, cell lysates were incubated with
anti-ULK1 antibody or FLAG (M2) bead (Sigma) for 12 h at 4 C.
After adding protein A/G-Bead (Santa Cruz Biotechnology), themix-
tures were incubated for additional 6 h at 4 C. The immunocom-
plexes were washed ﬁve times with PBS, solubilized with sample
buffer lacking b-mercaptoethanol, and detected by Western
blotting.
2.7. Immunostaining
Cells grown on coverslips were ﬁxed with 4% paraformalde-
hyde, permeabilized with 0.1% Triton X-100, and blocked with 1%
BSA. After incubation with antibody and Hoechst 33258, cells were
visualized under an LSM confocal ﬂuorescence microscope (Zeiss).
2.8. RT-PCR
Total RNA was puriﬁed using Trizol reagent (Ambion) according
to the manufacturer’s instructions. The following primer sets were
used for PCR: p62, forward 50-ATG GCC ATG TCC TAC GTG AAG GAT
G-30 and reverse 50-AGA GGG CTA AGG GCA GCT GCC ACA C-30;
b-actin, forward 50-GAG CTG CCT GAC GGC CAG G-30 and reverse
50-CAT CTG GAA GGT GGA C-30.
2.9. Statistical analysis
Differences between groups were analyzed using one-way anal-
ysis of variance (ANOVA) followed by Tukey’s post hoc test, or
Student’s t-test, as appropriate. Error bars represent S.D. or
S.E.M., as indicated. P < 0.05 was considered statistically
signiﬁcant.3. Results
3.1. Establishment of the ULK1-VN/ATG9-VC BiFC assay to screen for
autophagy activators
Based on the previous reports showing that Atg1 interacts with
Atg9 in Drosophila and yeast [24,25], we examined whether ULK1
interacts with ATG9 in mammalian cells. Data from the immuno-
precipitation assay revealed that ATG9-FLAG interacted with
HA-ULK1 in the transfected cells (Fig. 1A and B). We further found
that endogenous ATG9 was immunoprecipitated together with
ULK1 (Fig. 1C), indicating that ULK1 interacts with ATG9 in mam-
malian cells. These results led us to establish a screening assay to
identify autophagy modulators. Since the BiFC assay is a tool to
observe protein–protein interactions in living cells, we adopted
this method to identify novel proteins that regulate the initiation
step of autophagy around ULK1.
To establish the BiFC assay, ULK1 was fused to the N-terminus
of the Venus vector (ULK-VN), while ATG9 was fused to the
C-terminus of the vector (ATG9-VC) (Fig. S1A). In the immunopre-
cipitation assay, we detected an interaction between ULK1-VN and
ATG9-VC, which was apparently increased under serum starvation
(Fig. 1D). Western blot analysis also revealed that serum starvation
following ectopic expression of both ULK1-VN and ATG9-VC
Fig. 1. Establishment of the ULK1-VN/ATG9-VC BiFC assay to screen autophagy activators. (A and B) Interaction between ATG9-FLAG and HA-ULK1 in mammalian cells.
HEK293T cells were co-transfected with pATG9-FLAG and pHA-ULK1 for 24 h. Cell extracts were subjected to immunoprecipitation (IP) assay with anti-HA antibody (A) or
anti-FLAG (M2) antibody (B). The immunoprecipitates and whole cell lysates (WCL) were analyzed by Western blot analysis. (C) Endogenous interaction between ULK1 and
ATG9. HEK293T cell extracts were subjected to immunoprecipitation assay using anti-ULK1 antibody. (D) Increased interaction between FLAG-ULK1-VN and HA-ATG9-VC
under serum starvation. HEK293T cells were co-transfected with pHA-ATG9-VC and pFLAG-ULK1-VN for 19 h and then incubated with serum-supplemented or serum-free
medium for an additional 3 h. Cell extracts were immunoprecipitated with anti-FLAG (M2) antibody. (E) Visualization of ULK1-VN/ATG9-VC association in living cells.
HEK293T cells were co-transfected with pHA-ATG9-VC and pFLAG-ULK1-VN for 19 h and then incubated with serum-supplemented, Rapamycin-containing (0.1 lg/mL)
(Rapamycin), serum-free {Serum ()}, or amino acid-free medium (EBSS) for additional 3 h. Green ﬂuorescence images of the complementation were acquired under a
ﬂuorescence microscope (GFP channel). Relative intensity of the BiFC ﬂuorescence was measured using Multi Gauge V3.0 (Fuji ﬁlm). Bars represent mean values ± S.E.M
(n = 100). ***P < 0.001. (F) Competition assay showing the speciﬁc interaction between ULK1-VN and ATG9-VC. HEK293T cells were co-transfected with pFLAG-ULK1-VN, pHA-
ATG9-VC, and either pATG9 (cold ATG9) or pULK1 (cold ULK1) and cultivated in growth medium for 24 h. GFP signals were observed under a ﬂuorescence microscope and the
relative intensity of the BiFC ﬂuorescence was measured. **P < 0.01, ***P < 0.001.
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and ubiquitin-conjugates (Fig. S1B and C). Following co-expression
of ULK1-VN and ATG9-VC, we visualized the GFP-positive signal
under a ﬂuorescence microscope. Interestingly, various autophagicFig. 2. Ectopic expression of G6PT increased autophagy. (A) Enhanced BiFC signals of UL
pHA-ATG9-VC, pFLAG-ULK1-VN, and either pcDNA3-HA (Ctrl) or pG6PT-HA for 24 h. Gre
microscope (GFP channel) (upper) and quantiﬁed using Multi Gauge V3.0 (Fuji ﬁlm) (
expression. After transfection with pHA-ATG9-VC, pFLAG-ULK1-VN, and either pc
immunoprecipitation assay using anti-FLAG (M2) antibody. (C and D) Increase of aut
either untreated or exposed to 10 nM Baﬁlomycin A1 (Baf. A1) for 2 h and cell extracts we
transfected with pEGFP-LC3 for 24 h in the presence or absence of 10 nM Baf. A. Cells
**P < 0.01, ***P < 0.001. (E and F) Regulation of autophagic ﬂux by G6PT expression. H
pmCherry-GFP-LC3 for 24 h. After ﬁxing the cells with 4% paraformaldehyde, green (uppe
(F). The number of LC3 puncta showing GFP+/RFP+ or GFP/RFP+ were counted and repre
Beclin1 and ATG5-dependent regulation of G6PT-mediated autophagic ﬂux. Hep3B/Ctrl a
or Beclin1 shRNA for 72 h (G). The m5-7 cells were left untreated or treated with 10 ng/
with pEGFP-LC3 and pcDNA3-HA (Ctrl) or pG6PT-HA for 24 h (H). Cell extracts were sustimuli signiﬁcantly increased the ﬂuorescence intensity in cells
expressing ULK1-VN/ATG9-VC, as compared with the control cells
(Fig. 1E). In addition, results from the competition assays showed
that overexpression of the free form of either ATG9 or ULK1K1-VN/ATG9-VC by G6PT overexpression. HEK293T cells were co-transfected with
en ﬂuorescence images of the complementation were acquired under a ﬂuorescence
lower). *P < 0.05. (B) Enhanced binding between ATG9-VC and ULK1-VN by G6PT
DNA3-HA or pG6PT-HA for 24 h, HEK293T cell extracts were analyzed with
ophagy activity by G6PT expression. Hep3B/Ctrl and Hep3B/G6PT-HA cells were
re subjected toWestern blot analysis (C). Hep3B/Ctrl and Hep3B/G6PT-HA cells were
showing GFP-LC3 puncta (>5) were counted under a ﬂuorescence microscope (D).
ep3B/Ctrl and Hep3B/G6PT-HA cells grown on coverslips were transfected with
r) and red (middle) ﬂuorescence images were acquired under a confocal microscope
sented with bars (mean values ± S.E.M., n = 15). **P < 0.01, ***P < 0.001 (E). (G and H)
nd Hep3B/G6PT-HA cells were co-transfected with pEGFP-LC3 and pSuper-neo (Ctrl)
mL doxycycline for 3 days to induce Atg5 depletion. Cells were then co-transfected
bjected to Western blot analysis (insert). *P < 0.05, ***P < 0.001.
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the ﬂuorescence intensity produced by BiFC (Fig. 1F), indicating
that the ﬂuorescence signal detected in the BiFC assay reﬂects
the speciﬁc interaction between ULK1-VN and ATG9-VC. These
results indicate that the ULK1-VN/ATG9-VC BiFC assay can be used
as a tool for studying the interaction between ULK1 and ATG9, and
to identify autophagy regulators that modulate this interaction.3.2. Identiﬁcation of G6PT as an autophagy activator by cell-based
functional screening
By utilizing the ULK1-VN/ATG9-VC BiFC assay, we performed
functional screening to identify potential autophagy activators
upstream of ULK1. Total 14 positive clones that increased the
intensity of BiFC were selected among 500 genes that encode endo-
plasmic reticulum- or lysosome-resident proteins. Because G6PT
was the most potent activator among them, we further character-
ized the autophagic function of G6PT. As predicted, compared to
control cells, ectopic expression of G6PT increased the intensity
of BiFC (Fig. 2A). Further, data from the immunoprecipitation assayFig. 3. Reduction of G6PT expression impaired autophagy. (A) Generation of stable G6P
G6PT shRNAs and selected with 1 mg/mL G418 for 2 weeks. Stable Hep3B/G6PT shRNA ce
analysis. (B) Reduced autophagic ﬂux in G6PT-knockdown cells. Hep3B/Ctrl and Hep3B/G
(Baf. A1) for 90 min and then analyzed by Western blot analysis. (C) Accumulation of p62
4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with anti-p62
acquired using a confocal microscope (upper) and the amounts of p62 were quantiﬁed (l
and E) Increased aggregation of mutant Huntingtin by G6PT depletion. Hep3B/Ctrl and H
Cell lysates were subjected to a ﬁlter trap assay and the blots were analyzed by Western b
HEK293T cells were transfected with pSuper-neo (Ctrl) or G6PT shRNAs for 24 h and fur
aggregates were counted under a ﬂuorescence microscope (E). **P < 0.01.conﬁrmed that G6PT overexpression increased the interaction
between ULK1-VN and ATG9-VC (Figs. 2B and S2A).
To investigate whether G6PT could enhance autophagic ﬂux, we
generated G6PT-HA-overexpressing Hep3B cells (Fig. S2B).
Western blot analysis showed that LC3-II conversion was increased
in Hep3B/G6PT-HA cells as compared with control cells, and this
increment was further enhanced by the treatment with
Baﬁlomycin A1, a lysosomal inhibitor (Fig. 2C). This indicates that
the increment of LC3-II conversion is due to the activation of
autophagy. Similar results were observed using the GFP-LC3
puncta formation assay (Fig. 2D). Autophagic ﬂux was further
assessed with the mCherry-GFP-LC3 assay in which
mCherry-only signal is increased during autophagy activation
[14]. We found an increase in the number of mCherry-LC3 puncta
(5-folds) as well as yellow LC3 puncta (2-folds) in Hep3B/G6PT-HA
cells (Fig. 2E and F). Transient expression of G6PT also activated
autophagy in HEK293T cells (Fig. S2C).
The depletion of Beclin1, a key component of class III PI3K com-
plex that regulates autophagy at the initiation step, blocked the
increase in GFP-LC3 puncta induced by G6PT expression
(Fig. 2G). As a recent study reported that alternativeT-knockdown Hep3B cells. Hep3B cells were transfected with pSuper-neo (Ctrl) or
lls (#1 and #2) showing reduced expression of G6PT were selected by Western blot
6PT shRNA cells (#1 and #2) were left untreated or exposed to 10 nM Baﬁlomycin A1
in G6PT-knockdown cells. Hep3B/Ctrl and Hep3B/G6PT shRNA cells were ﬁxed with
antibody (red channel) and Hoechst 33258 (blue channel) for nuclei. Images were
ower). Baf. A1-treated Hep3B/Ctrl cells were used as a positive control. *P < 0.05. (D
ep3B/G6PT shRNA cells were transfected with pHTTex120Q-GFP (mtHTT) for 24 h.
lotting using anti-GFP antibody. Ponceau S staining was used as loading control (D).
ther transfected with pHTTex 120Q-GFP (mtHTT) for additional 24 h. Cells showing
Fig. 4. G6PT stimulated autophagy activation independent of its transport activity. (A and B) Effects of G6PT transport activity-dead mutants on autophagy. HEK293T cells
were transfected with various G6PT transport activity-dead mutants for 24 h. Cell extracts were analyzed by Western blotting (A). Hep3B cells were co-transfected with
pEGFP-LC3 and G6PT transport activity-dead mutants for 24 h. Cells showing GFP-LC3 puncta were counted under a ﬂuorescence microscope (B). **P < 0.01, ***P < 0.001. (C)
Effects of G6PT transport activity-dead mutants on the ﬂuorescence intensity of ULK1-VN/ATG9-VC BiFC. HEK293T cells were co-transfected with pFLAG-ULK1-VN, pHA-
ATG9-VC, and pG6PT-HA mutants for 24 h and observed under a ﬂuorescence microscope. The ﬂuorescence intensity of BiFC complex was quantiﬁed using Multi Gauge V3.0
(Fuji ﬁlm). **P < 0.01, ***P < 0.001. (D and E) Effects of chlorogenic acid on G6PT-mediated autophagy. HEK293T cells were treated with 1 mM chlorogenic acid (CHA) for 24 h
and then treated with 10 nM Baﬁlomycin A1 (Baf. A1) for additional 2 h. Cell extracts were subjected to Western blot analysis (D). Hep3B cells were transfected with pEGFP-
LC3 for 16 h and exposed to 1 mM CHA for additional 24 h (E). (F) Schematic diagram of G6PT deletion mutants. (G and H) Domain mapping of G6PT for autophagy
stimulation. Hep3B cells were co-transfected with pEGFP-LC3 and G6PT deletion mutants for 24 h. *P < 0.05, ***P < 0.001 (G). HEK293T cells were transfected with G6PT-HA
deletion mutants for 24 h and then exposed to 5 lM MG132 for additional 6 h. Cell extracts were subjected to Western blot analysis (H).
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tested whether this mechanism is involved in G6PT-induced
autophagy using conditional Atg5-knockout mouse embryo ﬁbrob-
lasts (MEFs) [30]. Similar to the results obtained from experimentsFig. 5. Knockdown of G6PT expression activated mTORC1 activity. (A–C) Decrease of LC
starvation. Hep3B/Ctrl and Hep3B/G6PT shRNA cells were incubated with EBSS for 2 h
shRNA cells were transfected with pEGFP-LC3 for 24 h and then incubated with EBSS fo
microscope. *P < 0.05, ***P < 0.001 (B). Hep3B/Ctrl and Hep3B/G6PT shRNA cells were ex
Increase of mTORC1 activity by G6PT depletion. Hep3B/Ctrl and Hep3B/G6PT shRNA cel
exposure; long, long exposure. Relative intensity of the Western blot was measured usin
glucose depletion. Hep3B/Ctrl and Hep3B/G6PT shRNA cells were exposed to glucose-fre
Western blot was measured using ImageJ 1.48v (E). Hep3B/Ctrl and Hep3B/G6PT shRN
medium for additional 2 h. Cells showing GFP-LC3 puncta were counted under a ﬂuoresusing Hep3B cells, ectopic expression of G6PT increased GFP-LC3
puncta formation in wild-type but not Atg5/ MEFs (Fig. 2H).
This indicates that G6PT activates autophagy in an
ATG5-dependent manner.3 puncta formation and LC3-II conversion by G6PT knockdown under amino acid
and immunostained with anti-LC3 antibody (A). Hep3B/Ctrl cells and Hep3B/G6PT
r additional 2 h. Cells showing GFP-LC3 puncta were counted under a ﬂuorescence
posed to EBSS for 2 h and cell extracts were analyzed by Western blotting (C). (D)
ls were exposed to EBSS for 2 h and subjected to Western blot analysis. short, short
g ImageJ 1.48v. (E and F) Suppression of AMPK activity by G6PT knockdown under
e medium for 2 h and subjected to Western blot analysis. Relative intensity of the
A cells were transfected with pEGFP-LC3 for 24 h and incubated with glucose-free
cence microscope (F). **P < 0.01, ***P < 0.001.
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by inhibiting autophagy activity
Subsequently, we generated stable G6PT knockdown Hep3B
cells (Hep3B/G6PT-shRNA #1 and #2) to assess the effects of
G6PT knockdown on autophagy (Fig. 3A). In comparison with con-
trol cells, Hep3B/G6PT shRNA cells exhibited a reduced basal level
of LC3-II and an increased accumulation of ubiquitin-conjugates
and p62, an autophagy substrate (Fig. 3B) [31]. Similarly, the level
of endogenous p62 aggregates was enhanced in G6PT-knockdown
cells (Fig. 3C). The change of p62 level was not due to an alteration
in the mRNA level (Fig. S3). We also measured the aggregation of
mutant Huntingtin (mtHTT), an autophagy substrate [14], in
G6PT knockdown cells. Using the dot blot analysis and ﬁlter trap
assay, we found that knockdown of G6PT expression increased
the aggregation of GFP-fused mtHTT (Fig. 3D and E). Consistent
with the stimulatory effects of G6PT expression on autophagy,
these results indicate that G6PT is crucial in autophagy activation.
3.4. G6PT modulated autophagy independent of its transport activity
Because G6PT functions as a transporter that dispatches cytoso-
lic G6P into the ER lumen, we addressed whether the transport
activity of G6PT is associated with its autophagy activity. Based
on a previous report [32], we generated several transport
activity-dead mutants of G6PT and tested their effects on autop-
hagy. Like wild-type G6PT, all of the G6PT transport activity-dead
mutants increased the levels of LC3-II conversion, GFP-LC3 positive
puncta, and the ﬂuorescence intensity in the ULK1-VN/ATG9-VC
BiFC assay (Fig. 4A–C). Further, treatment with chlorogenic acid
(CHA), an inhibitor of G6PT [33], did not inhibit LC3-II conversion
and GFP-LC3 puncta formation (Fig. 4D and E). Consistently,
G6PT could activate autophagy in HT22 cells that are defective in
gluconeogenesis (Fig. S4). These results indicate that G6PT affects
autophagy activity in a transport activity-independent manner.
The transport activity-independent function of G6PT in autop-
hagy stimulation led us to deﬁne the functional domain responsi-
ble for autophagy in G6PT. We generated C-terminal deletion
mutants of G6PT (Fig. 4F) and tested their activities in autophagy.
In comparison with wild-type, G6PT deletion mutants were rapidly
degraded in the transfected cells and thus detected only in the
presence of MG132, a proteasome inhibitor. G6PT deletion mutants
containing the N-terminal 4 or 8 transmembrane domains but
lacking the C-terminal transmembrane domains failed to increase
GFP-LC3 puncta formation and LC3-II conversion (Fig. 4G and H),
indicating that the C-terminal region of G6PT may be required
for its autophagy activity.
3.5. G6PT activated autophagy by inhibiting mTORC1 during amino
acid starvation
In addition to its contribution to basal autophagy, we further
assessed the role of G6PT in induced autophagy, such as amino acid
starvation. Surprisingly, under amino acid starvation (with EBSS),
the formation of both endogenous and ectopic LC3-positive puncta
was abolished in Hep3B/G6PT shRNA but not in Hep3B control cells
(Fig. 5A and B). Additionally, LC3-II level and subcellular distribu-
tion of ATG9-GFP were impaired in Hep3B/G6PT shRNA cells dur-
ing amino acid starvation (Figs. 5C, S5A and B). Further, Western
blot analysis illustrated that G6PT knockdown increased the level
of phosphorylated S6 kinase (Thr 389) and 4E-BP1 (Thr 37/46),
direct substrates of mTORC1 [34], and this increment was elimi-
nated by the treatment with Rapamycin, a mTORC1 inhibitor
(Figs. 5D and S5C). Rapamycin treatment also restored the level
of LC3-II in Hep3B/G6PT shRNA cells (Fig. S5C).Simultaneously, ULK1 phosphorylation S638 by mTORC1 was
increased by G6PT knockdown but decreased by G6PT overexpres-
sion in Hep3B cells (Fig. S5D and S5E). On the other hand, the phos-
phorylation of ULK S555 by AMPKa was increased by G6PT
overexpression. Likewise wild-type G6PT, G6PT mutants similarly
regulate mTORC1 and AMPKa (Fig. S5E). In addition, we observed
that under glucose starvation, G6PT knockdown reduced LC3-II
conversion and the level of phosphorylated AMPK (T172)
(Fig. 5E and F). Together, these data indicate that G6PT regulates
autophagy through the inhibition of mTORC1 and activation of
AMPK.
4. Discussion
In this study, we aimed to identify new regulators functioning
at the initiation stage of autophagy. Based on a recent study show-
ing a functional and physical interaction between Atg1, an ULK1
homolog, and Atg9 in yeast [24], we developed a functional screen-
ing assay using the BiFC system to detect autophagy activation.
Compared with the LC3 measurement assays, the BiFC assay using
ULK1-VN and ATG9-VC provides an advantage in that ﬂuorescence
signal is generated only by autophagy activation but not autophagy
inhibition, thus facilitating the successful identiﬁcation of autop-
hagy activators from a cDNA library. In particular, this assay is a
viable method in monitoring the initiation step of autophagy
upstream of ULK1 andATG9.
Similar to the case in yeast and Drosophila, we observed the pro-
tein–protein interactions between ULK1 and ATG9 in mammalian
cells with immunoprecipitation assays. Unlike in BiFC assays in
which autophagy stimuli increased the ﬂuorescence, we could
not ﬁnd convincing evidence showing that the interaction between
endogenous ULK1 and ATG9 was regulated during autophagy in
mammalian cells. In yeast, Atg1 has been shown to regulate Atg9
through their association [24]. The absence of regulated interaction
between endogenous ULK1 and ATG9 in mammalian cells may
arise from a difference in the mode of interaction between ULK1
and ATG9 in yeast and mammalian cells. Alternatively, it may be
easier to observe the regulated interaction between ULK1 and
ATG9 in the BiFC assay than in the immunoprecipitation assay,
since the interaction in the BiFC assay is irreversible [35].
Therefore, the mode of interaction between ULK1 and ATG9 in
mammalian cells, whether direct or indirect, remains to be further
elucidated.
Although G6PT serves to transport G6P into the ER lumen dur-
ing the cascade of gluconeogenesis or glycogenolysis to produce
glucose, we could not observe any positive relationship between
the transport activities of G6PT and autophagy. Accumulating evi-
dence has implied that G6PT may have functions other than glu-
cose production. First, G6PT is expressed all over the organ
whereas G6Pase-a is only expressed in the liver and kidney.
Second, GSD1b patients who carry G6PT mutations exhibit differ-
ent symptoms from GSD1a patients who bear G6Pase malfunction.
In addition to disruption of glucose homeostasis, GSD1b patients
show neutropenia [36]. Interestingly, although GSD1b patients
have the same mutation in G6PT gene, the severity of neutropenia
in the patients and their corresponding therapies are different [37].
Recently, a G6pt/ mouse model was developed to study the
potential roles of G6PT beyond glucose homeostasis in neutrophil
cells. While G6pt/ mice show same phenotype as G6Pase deﬁ-
ciency which is characterized by growth retardation, hypo-
glycemia, hepatomegaly, and nephromegaly, G6pt/ mice also
showed myeloid dysfunction, altered hematopoiesis in the bone
marrow and spleen, abnormal chemokine production and impaired
calcium ﬂux in neutrophils [38]. Although a number of studies are
in progress, the relationship between neutropenia severity and
2108 H.-H. Ahn et al. / FEBS Letters 589 (2015) 2100–2109transport activity of G6PT has not been clearly revealed. For these
reasons, we suggest that the autophagy-stimulatory activity of
G6PT independent of its transport activity may be one of the addi-
tional functions of G6PT. We therefore encourage further investiga-
tion in identifying the functions of G6PT in autophagy and
neutropenia on GSD1b patients.
In our study, G6PT-mTORC1 signaling is essential in promoting
autophagy in hepatic cell line. Malfunction of mTORC1 is fre-
quently associated with metabolic diseases, including type 2 dia-
betes and cancer [39]. Additionally, high levels of glucose in
hepatic cells due to uncontrolled G6PT expression is widely
observed in type 2 diabetic patients [40]. Our observation that
G6PT regulates mTORC1 and autophagy may provide a new way
to interpret the role of G6PT in metabolic syndromes. In addition,
G6PT is localized to the ER membrane whereas activated
mTORC1 is found in the lysosome. Therefore, a question remains
as to how G6PT regulates mTORC1. One possible explanation is
that G6PT regulates mTORC1 through calcium mobilization,
because a recent study has revealed that knockdown of G6PT
expression disrupts calcium mobilization in glioblastoma cells
[38]. Consistently, mTORC1 is regulated by VPS34 in a calcium
channel-dependent manner in the lysosome [41]. Especially, our
observation that G6PT regulates AMPK during glucose
starvation-induced autophagy suggests a pivotal role of G6PT in
the regulation of mTORC1 through AMPK. AMPK is an energy sen-
sor activated in response to increased cellular AMP, ADP or Ca2+
level and is phosphorylated by LKB1 and
Ca2+/calmodulin-activated protein kinase P (CaMKKP) [42].
Because AMPK regulates autophagy through either direct phospho-
rylation of ULK1 or inhibition of mTORC1 [43], disruption of cal-
cium mobilization caused by G6PT dysfunction might affect both
AMPK and mTORC1, resulting in inhibition of autophagy.
In conclusion, we have established a functional screening assay
using the BiFC system to study the interaction between ULK1 and
ATG9. This assay enabled us to identify G6PT as a speciﬁc modula-
tor of the initiation step of autophagy.Acknowledgments
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